Cargando…
_version_ 1784670977369571328
author Gonzalez, Michael A
Boonyaratanakornkit, Jim
Bhatti, Atif
Keane-Candib, Jacob
Huang, Meei-Li
Campbell, Victoria
Goecker, Erin
Ibrahimi, Sarah
Hecht, Jessica
McClurkan, Christopher
Greninger, Alexander
Koelle, David M
Hill, Joshua A.
author_facet Gonzalez, Michael A
Boonyaratanakornkit, Jim
Bhatti, Atif
Keane-Candib, Jacob
Huang, Meei-Li
Campbell, Victoria
Goecker, Erin
Ibrahimi, Sarah
Hecht, Jessica
McClurkan, Christopher
Greninger, Alexander
Koelle, David M
Hill, Joshua A.
author_sort Gonzalez, Michael A
collection PubMed
description
format Online
Article
Text
id pubmed-8930046
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-89300462022-03-18 Comparison of Humoral and T-Cell Response after Sars-Cov-2 Vaccination Among Patients before and after Chimeric Antigen Receptor-Modified T Cell (CAR-T cell) Therapy Gonzalez, Michael A Boonyaratanakornkit, Jim Bhatti, Atif Keane-Candib, Jacob Huang, Meei-Li Campbell, Victoria Goecker, Erin Ibrahimi, Sarah Hecht, Jessica McClurkan, Christopher Greninger, Alexander Koelle, David M Hill, Joshua A. Transplant Cell Ther Poster Session - Car-T - Clinical - Regulatory, Efficacy, Persistence American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2022-03 2022-03-18 /pmc/articles/PMC8930046/ http://dx.doi.org/10.1016/S2666-6367(22)00425-0 Text en Copyright © 2022 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Poster Session - Car-T - Clinical - Regulatory, Efficacy, Persistence
Gonzalez, Michael A
Boonyaratanakornkit, Jim
Bhatti, Atif
Keane-Candib, Jacob
Huang, Meei-Li
Campbell, Victoria
Goecker, Erin
Ibrahimi, Sarah
Hecht, Jessica
McClurkan, Christopher
Greninger, Alexander
Koelle, David M
Hill, Joshua A.
Comparison of Humoral and T-Cell Response after Sars-Cov-2 Vaccination Among Patients before and after Chimeric Antigen Receptor-Modified T Cell (CAR-T cell) Therapy
title Comparison of Humoral and T-Cell Response after Sars-Cov-2 Vaccination Among Patients before and after Chimeric Antigen Receptor-Modified T Cell (CAR-T cell) Therapy
title_full Comparison of Humoral and T-Cell Response after Sars-Cov-2 Vaccination Among Patients before and after Chimeric Antigen Receptor-Modified T Cell (CAR-T cell) Therapy
title_fullStr Comparison of Humoral and T-Cell Response after Sars-Cov-2 Vaccination Among Patients before and after Chimeric Antigen Receptor-Modified T Cell (CAR-T cell) Therapy
title_full_unstemmed Comparison of Humoral and T-Cell Response after Sars-Cov-2 Vaccination Among Patients before and after Chimeric Antigen Receptor-Modified T Cell (CAR-T cell) Therapy
title_short Comparison of Humoral and T-Cell Response after Sars-Cov-2 Vaccination Among Patients before and after Chimeric Antigen Receptor-Modified T Cell (CAR-T cell) Therapy
title_sort comparison of humoral and t-cell response after sars-cov-2 vaccination among patients before and after chimeric antigen receptor-modified t cell (car-t cell) therapy
topic Poster Session - Car-T - Clinical - Regulatory, Efficacy, Persistence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930046/
http://dx.doi.org/10.1016/S2666-6367(22)00425-0
work_keys_str_mv AT gonzalezmichaela comparisonofhumoralandtcellresponseaftersarscov2vaccinationamongpatientsbeforeandafterchimericantigenreceptormodifiedtcellcartcelltherapy
AT boonyaratanakornkitjim comparisonofhumoralandtcellresponseaftersarscov2vaccinationamongpatientsbeforeandafterchimericantigenreceptormodifiedtcellcartcelltherapy
AT bhattiatif comparisonofhumoralandtcellresponseaftersarscov2vaccinationamongpatientsbeforeandafterchimericantigenreceptormodifiedtcellcartcelltherapy
AT keanecandibjacob comparisonofhumoralandtcellresponseaftersarscov2vaccinationamongpatientsbeforeandafterchimericantigenreceptormodifiedtcellcartcelltherapy
AT huangmeeili comparisonofhumoralandtcellresponseaftersarscov2vaccinationamongpatientsbeforeandafterchimericantigenreceptormodifiedtcellcartcelltherapy
AT campbellvictoria comparisonofhumoralandtcellresponseaftersarscov2vaccinationamongpatientsbeforeandafterchimericantigenreceptormodifiedtcellcartcelltherapy
AT goeckererin comparisonofhumoralandtcellresponseaftersarscov2vaccinationamongpatientsbeforeandafterchimericantigenreceptormodifiedtcellcartcelltherapy
AT ibrahimisarah comparisonofhumoralandtcellresponseaftersarscov2vaccinationamongpatientsbeforeandafterchimericantigenreceptormodifiedtcellcartcelltherapy
AT hechtjessica comparisonofhumoralandtcellresponseaftersarscov2vaccinationamongpatientsbeforeandafterchimericantigenreceptormodifiedtcellcartcelltherapy
AT mcclurkanchristopher comparisonofhumoralandtcellresponseaftersarscov2vaccinationamongpatientsbeforeandafterchimericantigenreceptormodifiedtcellcartcelltherapy
AT greningeralexander comparisonofhumoralandtcellresponseaftersarscov2vaccinationamongpatientsbeforeandafterchimericantigenreceptormodifiedtcellcartcelltherapy
AT koelledavidm comparisonofhumoralandtcellresponseaftersarscov2vaccinationamongpatientsbeforeandafterchimericantigenreceptormodifiedtcellcartcelltherapy
AT hilljoshuaa comparisonofhumoralandtcellresponseaftersarscov2vaccinationamongpatientsbeforeandafterchimericantigenreceptormodifiedtcellcartcelltherapy